279 related articles for article (PubMed ID: 28315938)
1. The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.
Glajcar A; Szpor J; Pacek A; Tyrak KE; Chan F; Streb J; Hodorowicz-Zaniewska D; Okoń K
Virchows Arch; 2017 May; 470(5):505-515. PubMed ID: 28315938
[TBL] [Abstract][Full Text] [Related]
2. Quantitative mast cell analysis and hormone receptor study (ER, PR and HER2/neu) in invasive carcinoma of breast.
Pyla RD; Potekar RM; Patil VS; Reddy AK; Sathyashree KV
Indian J Pathol Microbiol; 2020; 63(2):200-204. PubMed ID: 32317515
[TBL] [Abstract][Full Text] [Related]
3. Mast cell phenotype in benign and malignant tumors of the prostate.
Globa T; Saptefrţi L; Ceauşu RA; Gaje P; Cimpean AM; Raica M
Pol J Pathol; 2014 Jun; 65(2):147-53. PubMed ID: 25119176
[TBL] [Abstract][Full Text] [Related]
4. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT
Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240
[TBL] [Abstract][Full Text] [Related]
5. Mast Cells as an Indicator and Prognostic Marker in Molecular Subtypes of Breast Cancer.
Carpenco E; Ceauşu RA; Cimpean AM; Gaje PN; Șaptefraţi L; Fulga V; David V; Raica M
In Vivo; 2019; 33(3):743-748. PubMed ID: 31028192
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.
Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW
Breast; 2012 Feb; 21(1):50-7. PubMed ID: 21865043
[TBL] [Abstract][Full Text] [Related]
7. Mast cells in diffuse large B-cell lymphoma; their role in fibrosis.
Fukushima H; Ohsawa M; Ikura Y; Naruko T; Sugama Y; Suekane T; Kitabayashi C; Inoue T; Hino M; Ueda M
Histopathology; 2006 Nov; 49(5):498-505. PubMed ID: 17064296
[TBL] [Abstract][Full Text] [Related]
8. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
Badowska-Kozakiewicz A; Sobol M; Patera J
Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
[TBL] [Abstract][Full Text] [Related]
9. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer.
Alnajar H; Rosen L; Javidiparsijani S; Al-Ghamdi Y; Gattuso P
Acta Cytol; 2017; 61(2):140-144. PubMed ID: 28231581
[TBL] [Abstract][Full Text] [Related]
11. High density of tryptase-positive mast cells in patients with renal cell carcinoma on hemodialysis: correlation with expression of stem cell factor and protease activated receptor-2.
Watanabe S; Miyata Y; Matsuo T; Mochizuki Y; Nishikido M; Hayashi T; Sakai H
Hum Pathol; 2012 Jun; 43(6):888-97. PubMed ID: 22204707
[TBL] [Abstract][Full Text] [Related]
12. Allelic imbalance at the HER2/TOP2A locus in breast cancer.
Huijsmans CJ; van den Brule AJ; Rigter H; Poodt J; van der Linden JC; Savelkoul PH; Hilbink M; Hermans MH
Diagn Pathol; 2015 May; 10():56. PubMed ID: 26022247
[TBL] [Abstract][Full Text] [Related]
13. High tumor mast cell density is associated with longer survival of colon cancer patients.
Mehdawi L; Osman J; Topi G; Sjölander A
Acta Oncol; 2016 Dec; 55(12):1434-1442. PubMed ID: 27355473
[TBL] [Abstract][Full Text] [Related]
14. [Survival of patients with metastatic breast cancer according to pathological types of tumors].
Sánchez R C; Acevedo C F; Petric G M; Galindo A H; Domínguez C F; León R A; Razmilic V D; Ceballos C; Espinoza F; Navarro O ME; Oddó B D; Camus A M
Rev Med Chil; 2014 Apr; 142(4):428-35. PubMed ID: 25117032
[TBL] [Abstract][Full Text] [Related]
15. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a peruvian hospital database.
Vallejos CS; Gómez HL; Cruz WR; Pinto JA; Dyer RR; Velarde R; Suazo JF; Neciosup SP; León M; de la Cruz MA; Vigil CE
Clin Breast Cancer; 2010 Aug; 10(4):294-300. PubMed ID: 20705562
[TBL] [Abstract][Full Text] [Related]
17. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions.
Kankkunen JP; Harvima IT; Naukkarinen A
Int J Cancer; 1997 Jul; 72(3):385-8. PubMed ID: 9247277
[TBL] [Abstract][Full Text] [Related]
19. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
